HELICOBACTER PYLORI INFECTION: A BIOINFORMATIC APPROACH

被引:12
|
作者
Prasad, Ashwini [1 ]
Shruthi, Govindaraju [1 ]
Sushma, P. [1 ]
Jain, Anisha S. [1 ]
Chandan, D. [1 ]
Prasad, M. N. Nagendra [2 ]
Kollur, Shiva Prasad
Srinivasa, Chandrashekar [3 ]
Shivamallu, Chandan [1 ]
机构
[1] JSS Acad Higher Educ & Res, Fac Life Sci, Dept Water & Hlth, Mysore 570015, Karnataka, India
[2] JSS Sci & Technol Univ, Sri Jayachamarajendra Coll Engn, Dept Biotechnol, Mysore 570015, Karnataka, India
[3] Davangere Univ, Dept Biotechnol, Davanagere 577007, Karnataka, India
关键词
In-silico Analysis; Molecular Docking; Molecular Interaction; Helicobacter pylori;
D O I
10.13040/IJPSR.0975-8232.11(11).5469-83
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Helicobacter pylori causative agent of acid peptic disease is a microaerophilic, spiral-shaped, gram-negative bacteria found in the gastric epithelium that may also lead to complications such as chronic gastritis, mucosa-associated lymphoid tissue (MALT) lymphoma, gastroduodenal ulcer and adenocarcinoma in stomach. Plantbioactives have always been potential therapeutics. Usage of modern bioinformatic tools plays a vital role in exploiting the potentials of alternative therapeutic molecules in managing diseases like peptic ulcers and their complications. The in-silico evaluation was carried out using molecular docking of the quorum sensing proteins of H. pylori with the ligand beta-sitosterol obtained from the silver nanoparticles of Acorus calamus L. Among several given quorum sensing proteins the molecular interaction with the ligand beta-sitosterol showed a high binding affinity with DnaA, PhnB, ToxB and Sip proteins. The results obtained from molecular interaction study revealed that the ligand beta-sitosterol will be readily taken up by the organism, thereby facilitating easy inhibition or inactivation of quorum sensing molecules ToxB, DnaA, PhnB, and Sip, making it a novel therapeutic alternative to treat H. pylori infections.
引用
收藏
页码:5469 / 5483
页数:15
相关论文
共 50 条
  • [31] Bioinformatic analysis of Helicobacter pylori XGPRTase:: A potential therapeutic target
    Duckworth, Megan
    Menard, Armelle
    Megraud, Francis
    Mendz, George L.
    HELICOBACTER, 2006, 11 (04) : 287 - 295
  • [32] Diagnosis of Helicobacter pylori infection and diseases associated with Helicobacter pylori by Helicobacter pylori outer membrane proteins
    Jiang, Zheng
    Huang, Ai-Long
    Tao, Xiao-Hong
    Wang, Pi-Long
    WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (23) : 3464 - 3469
  • [33] Helicobacter pylori infection and inflammasomes
    Zheng, Huiling
    Xia, Pengyan
    Fu, Weiwei
    Ding, Shigang
    HELICOBACTER, 2024, 29 (01)
  • [34] Helicobacter pylori infection in children
    Vandenplas, Y
    Blecker, U
    ACTA PAEDIATRICA, 1998, 87 (11) : 1105 - 1112
  • [35] Epidemiology of Helicobacter pylori infection
    Bruce, Michael G.
    Maaroos, Heidi Ingrid
    HELICOBACTER, 2008, 13 : 1 - 6
  • [36] Helicobacter pylori infection in geriatrics
    Pilotto, A
    Salles, N
    HELICOBACTER, 2002, 7 : 56 - 62
  • [37] Immunology of Helicobacter pylori infection
    Velin, Dominique
    Michetti, Pierre
    DIGESTION, 2006, 73 (2-3) : 116 - 123
  • [38] Epidemiology of Helicobacter pylori infection
    Burucoa, Christophe
    Axon, Anthony
    HELICOBACTER, 2017, 22
  • [39] Treatment of Helicobacter pylori infection
    Vakil, N
    Go, MF
    CURRENT OPINION IN GASTROENTEROLOGY, 2000, 16 (01) : 32 - 39
  • [40] Pathogenesis of Helicobacter pylori infection
    Hatakeyama, Masanori
    Brzozowski, Tomasz
    HELICOBACTER, 2006, 11 : 14 - 20